[ad_1] July 18, 2018. – The laboratory VIVAX has informed by a declaration, the voluntary withdrawal of products containing the active ingredient valsartan, such as Presincal, Valsartan and Varteral, due to the …
Read More »VIVAX laboratory voluntarily withdraws antihypertensive products containing Valsartan for possible contamination
